New hope for men with spread prostate cancer: targeted radiation may boost standard care

NCT ID NCT06150417

Recruiting now Disease control Sponsor: Case Comprehensive Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 21, 2026 · Updated 6 times

Summary

This study is for men with prostate cancer that has spread to a few other parts of the body at diagnosis. It tests whether adding radiation therapy directly to those cancer spots (called metastasis-directed radiotherapy) can help keep the cancer under control longer than the usual treatment of hormone therapy and prostate radiation alone. About 200 men will take part, receiving standard care plus either extra radiation or not. The goal is to see if the extra radiation delays cancer progression.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MALIGNANT NEOPLASM OF PROSTATE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

metastatic prostate carcinoma prostate adenocarcinoma prostate cancer secondary malignant neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MALIGNANT NEOPLASM OF PROSTATE PROSTATE CANCER SECONDARY MALIGNANT NEOPLASM OF PROSTATE

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Carbone Cancer Center University of Wisconsin-Madison
RECRUITING

Madison, Wisconsin, 53792, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact
University Hospitals Cleveland Medical Center Seidman Cancer Center
RECRUITING

Cleveland, Ohio, 44106, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.